Preeclampsia: From epidemiological observations to molecular mechanisms

Brazilian Journal of Medical and Biological Research

Volumn 34, Issue 10, 2001, Pages 1227-1235

  Lopez Jaramillo P ^a   Casas, J P ^a   Serrano, N ^a  

^a UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

Author keywords

Calcium supplementation; Endothelial dysfunction; Infection; Inflammation; Nitric oxide; Oxidative stress; Preeclampsia

Indexed keywords

ANTIBIOTIC AGENT; ANTIOXIDANT; CALCIUM; FREE RADICAL; LINOLEIC ACID; MINERAL; NITRIC ACID DERIVATIVE; NITRIC OXIDE; PEROXYNITRATE; SUPEROXIDE; UNCLASSIFIED DRUG; VITAMIN;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROL SYSTEM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPING COUNTRY; ENVIRONMENTAL FACTOR; FEMALE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; MOLECULAR BIOLOGY; NUTRITION; PATHOGENESIS; PERINATAL MORTALITY; PREECLAMPSIA; SUPPLEMENTATION; URINARY TRACT INFECTION; VAGINITIS; VASCULAR ENDOTHELIUM; VITAMIN SUPPLEMENTATION;

EID: 0034751623     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2001001000001     Document Type: Article

References (60)

1. Epidemiología de la hipertensión inducida por el embarazo: Situación nacional
2. Estudio hospitalario de mortalidad materna (Estudio 400)
3. Mortalidad materna en el Instituto Materno Infantil de Santanfé de Bogotá D.C. 1985-1989
4. Calcium, nitric oxide and preeclampsia
5. Role of malnutrition in pre-eclampsia and eclampsia
6. The relationship between calcium intake and edemaproteinuria and hypertension-gestosis: A hypothesis
7. Calcium supplementation reduces the risk of pregnancy induced hypertension in an Andean population
8. Dietary calcium supplementation and prevention of pregnancy hypertension
9. The clinical utility of the roll-over test in predicting pregnancy-induced hypertension in a high-risk Andean population
10. Calcium supplementation reduces the risk of preeclampsia in Ecuadorian pregnant teenagers
11. Prenatal diet, nutrient intake, and pregnancy outcome in urban Ecuadorian primiparas
12. Prevention of preeclampsia by linoleic acid and calcium supplementation: A randomized controlled trial
13. Calcium supplementation to prevent hypertensive disorders of pregnancy
14. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients
15. Calcium supplementation in nulliparous women for the prevention of pregnancy-induced hypertension, preeclampsia and preterm birth: An Australian randomized trial
16. Calcium supplementation in mild preeclampsia remote from term: A prospective randomized double-blind clinical trial
17. Calcium supplementation and prevention of pregnancy induced hypertension
18. Prevention of preeclampsia with calcium supplementation and vitamin D3 in an antenatal protocol
19. Trial of calcium for prevention of preeclampsia
20. Calcium supplementation during pregnancy: A systematic review of randomized controlled trials
21. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: A meta-analysis of randomized controlled trials
22. Dietary calcium and pregnancy-induced hypertension: Is there a relation?
23. Same nutrient, different hypotheses: Disparities in trials of calcium supplementation during pregnancy
24. Can meta-analysis be trusted?
25. Calcium metabolism
26. A clinical trial of the effects of dietary patterns on blood pressure
27. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems (Cochrane Review)
28. Cardiovascular hemodynamics in pregnancy and labor
29. The L-arginine: Nitric oxide pathway
30. Calcium supplementation prevents pregnancy-induced hypertension by increasing the production of vascular nitric oxide
31. Cyclic guanosine 3′, 5′ monophosphate concentrations in preeclampsia: Effects of hydralazine
32. Oxidised low-density lipoproteins and nitric oxide during normal pregnancy and preeclampsia
33. Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet
34. Constitutive NOS expression in cultured endothelial cells is elevated by fluid shear stress
35. Induction of calcium-dependent nitric oxide synthases by sex hormones
36. Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with pre-eclampsia
37. Nitric oxide production in women with preeclampsia
38. Elevated level of free 8-iso-prostaglandin F2alpha in the decidua basal of women with preeclampsia
39. Role of oxidative stress in cardiovascular diseases
40. Circulating markers of oxidative stress are raised in normal pregnancy and preeclampsia
41. Effect of antioxidants on the occurrence of preeclampsia in women at increased risk: A randomised trial
42. Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia
43. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia
44. Decreased renal and hepatic blood flow with preeclampsia-like histologic changes was obtained by stimulation of the celiac ganglion with LPS
45. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo
46. Acute systemic inflammation impairs endothelium-dependent dilatation in humans
47. Is C-reactive protein an independent risk factor for essential hypertension?
48. Reactive oxygen species and proinflammatory cytokine signaling in endothelial cells: Effect of selenium supplementation
49. Tumor necrosis factor-alpha in female reproductive tract
50. Immunoreactive tumor necrosis factor-α is elevated in maternal plasma but undetected in amniotic fluid in the second trimester
51. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with preeclampsia
52. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia
53. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin those of sepsis
54. Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with preeclampsia
55. Frequency of asymptomatic bacteriuria in preeclampsia
56. Urogenital infection in preeclampsia
57. Case-control study of the risk factors for preeclampsia
58. Preeclampsia. A nested, case-control study for risk factors and their interactions
59. Is infection a major risk factor for preeclampsia?
60. Role of L-arginine-nitric oxide pathway in normal pregnancy and preeclampsia